Kirkland & Ellis advises CICC as financial adviser to Shanghai Fosun New Medicine and Freshfields advises Shanghai Henlius Biotech on Fosun New Medicine’s proposed privatization of Shanghai Henlius Biotech by merger by absorption.

The Sponsor

Loading page...

Kirkland & Ellis advises CICC as financial adviser to Shanghai Fosun New Medicine and Freshfields advises Shanghai Henlius Biotech on Fosun New Medicine’s proposed privatization of Shanghai Henlius Biotech by merger by absorption. | The Sponsor - The Sponsor

$105.00 Billion deal in Privatisation

Kirkland & Ellis advises CICC as financial adviser to Shanghai Fosun New Medicine and Freshfields advises Shanghai Henlius Biotech on Fosun New Medicine’s proposed privatization of Shanghai Henlius Biotech by merger by absorption.

Kirkland & Ellis LLP

Overview

Freshfields

Lead Partners (3)

Edward Freeman

Grace Huang

David Yi

Overview

Found it useful? Spread the word.